Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
GLOBE LIFE INC. executive Robert Brian Mitchell, EVP, General Counsel and CRO, reported multiple equity awards and a related tax share disposition. He received an employee stock option grant for 12,600 shares at $0.0000 per share, first exercisable as to 50% of the shares on 02-27-2028 and the remaining 50% on 02-27-2029. He was also granted 9,394 shares of common stock and an additional 1,216 shares of common stock. To cover tax obligations, 3,697 common shares were disposed of at $144.1500 per share through a tax-withholding transaction. Following these transactions, he continues to hold common stock directly and also has indirect holdings through the Mitchell Family Trust, a Son's Trust, and a 401(k) Plan.
GLOBE LIFE INC. executive Michael Clay Majors, EVP and Chief Strategy Officer, reported multiple equity compensation movements. He received an employee stock option grant for 12,500 shares at an exercise price of $0.00 per share, first exercisable as to 50% of the shares on February 27, 2028 and the remaining 50% on February 27, 2029.
Majors also acquired 9,578 shares of common stock and an additional 1,140 shares as grants or awards, bringing his directly owned common stock to 53,518.447 shares after the later grant. In a separate tax-withholding transaction, 3,769 shares of common stock were disposed of at $144.15 per share to cover tax obligations, leaving 52,378.447 directly owned shares afterward.
Globe Life EVP & CFO Thomas Peter Kalmbach reported multiple equity awards and a related tax-share disposition. On February 27, 2026, he received an employee stock option for 18,500 shares at $0.00 per share, first exercisable as to half the shares on February 27, 2028 and the rest on February 27, 2029.
On the same date he was granted 1,738 shares of common stock. On February 25, 2026, he received an additional 9,762 shares of common stock and had 3,842 shares of common stock disposed at $144.15 per share to cover tax liabilities, leaving 36,016.0728 shares held directly afterward. He also reports indirect ownership of 1,146.485 shares through a 401(k) plan.
GLOBE LIFE INC. executive Robert Edward Hensley, EVP & Chief Investment Officer, reported a mix of equity awards and share sales. He received an employee stock option for 12,800 shares at an exercise price of $0.00, first exercisable as to 50% of the shares on February 27, 2028 and the remaining 50% on February 27, 2029. He was also granted 8,473 shares of common stock and an additional 1,235 shares as stock awards. To cover tax obligations, 3,335 shares of common stock were disposed of in a tax-withholding transaction at $144.15 per share. Separately, he sold 712 shares of common stock in an open-market or private transaction at $142.59 per share. After these transactions, his directly held common stock balance reported in one line was 17,052.9885 shares, with another line showing 14,952.9885 shares following a subsequent award.
GLOBE LIFE INC. senior vice president and chief accounting officer Michael Shane Henrie reported equity awards on common stock. He received a grant of 3,900 employee stock options at an exercise price of $0.00, first exercisable as to 50% of the shares on February 27, 2028 and the remaining 50% on February 27, 2029.
Henrie also acquired 1,099 shares of Globe Life common stock as a grant or award, bringing his directly held common stock to 3,975.0833 shares. In addition, 157.4510 shares are shown as indirectly held through a 401(k) plan, reflecting retirement plan holdings rather than a new purchase or sale.
GLOBE LIFE INC. Co-Chairman & CEO James Matthew Darden reported a mix of equity awards and stock sales. He received an employee stock option for 48,200 shares at an exercise price of $0.00 per share, first exercisable in two equal parts on 02-27-28 and 02-27-29. He was also granted 24,499 shares of common stock on 02-25-26 and 4,591 shares on 02-27-26. To cover tax obligations, 9,641 shares were disposed of at $144.15 per share. In open-market sales on 02-27-26, he sold 6,471 shares at an average price of $144.1381 and 3,056 shares at an average price of $144.7619, with sale prices ranging from about $143.56 to $145.15 per share. After these transactions, he directly held 53,860.4598 shares of common stock and 48,200 stock options, plus 4,185.585 shares held indirectly through a 401(k) plan.
GLOBE LIFE INC. executive Jennifer Allison Haworth, EVP & Chief Marketing Officer, reported equity compensation and a related tax share disposition. She received an employee stock option for 9,100 shares at a price of $0.00 per share, first exercisable as to 50% of the shares on February 27, 2028 and the remaining 50% on February 27, 2029. She was also granted 7,000 shares of common stock on February 25, 2026 and an additional 822 shares on February 27, 2026, both at $0.00 per share. To cover tax obligations, 2,755 shares of common stock were disposed of on February 25, 2026 at $144.15 per share, characterized as a payment of tax liability by delivering securities rather than an open‑market sale.
Globe Life Inc. expanded its Board of Directors from twelve to fourteen members and appointed Derek T. Kan and Sandra L. Phillips to fill the new seats effective February 25, 2026. They will serve until the April 30, 2026 Annual Meeting of Shareholders.
Both have been designated as independent directors under NYSE rules and company criteria. Mr. Kan joined the Audit Committee, while Ms. Phillips joined the Governance and Nominating Committee. Each new director will receive a prorated annual cash retainer of $110,000 and a prorated annual equity retainer of $190,000, with Mr. Kan also receiving a prorated $12,500 Audit Committee member retainer.
Globe Life Inc. reported a proposed sale of Common stock via a Form 144 registration. The filing lists restricted stock vesting entries dated 02/22/2026 and 02/25/2026, with a 7500 share entry shown for 02/25/2026.
GLOBE LIFE INC. director Derek T. Kan filed an initial statement of beneficial ownership of securities. The Form 3 shows he reported no Globe Life common stock beneficially owned, with zero shares listed as directly held and zero shares listed as indirectly held following the reported holdings.